Tuesday, December 23, 2025
Home Authors Posts by Ogkologos

Ogkologos

4103 POSTS 0 COMMENTS

Amivantamab Plus Lazertinib Shows Superior Efficacy to Osimertinib in First-Line Treatment...

Ogkologos -
0

Treatment with Brigatinib Results in Radiographic Responses and Clinical Benefit in...

Ogkologos -
0

Program Helps Medically Underserved, Minority Cancer Survivors Be More Active

Ogkologos -
0

Belantamab Mafodotin–Containing Triplets Confer a Significant PFS Benefit Among Previously Treated...

Ogkologos -
0

FDA Grants Traditional Approval to Selpercatinib for RET Fusion-positive Thyroid Cancer

Ogkologos -
0

Tumor Signatures May Help Explain Global Differences in Kidney Cancer Rates

Ogkologos -
0

Predictive Performance of DNA Methylation-based Test in Combination with HPV16/18 Genotyping...

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Germanium (68Ge) chloride /...

Ogkologos -
0

How Breast Cancer Risk Assessment Tools Work

Ogkologos -
0

With Longer Follow-Up, Trastuzumab Deruxtecan Continues to Demonstrate Superior Efficacy Over...

Ogkologos -
0
1...484950...411Page 49 of 411

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com